Dáil Éireann Debate, Tuesday - 17 February 2026
1138. Deputy Ken O'Flynn asked the Minister for Health whether her Department or the HSE has carried out any clinical risk assessment of patients with disabilities, cognitive impairment, or home-care dependency who rely on pharmacist-prepared monitored dosage systems to safely self-administer prescribed medicines; if so, the date of such assessment; the persons that conducted it; and if she will publish the findings. [12152/26]
Amharc ar fhreagra1139. Deputy Ken O'Flynn asked the Minister for Health whether any equality or disability impact assessment has been undertaken in respect of the exclusion of pharmacist-prepared monitored dosage systems from State funding under the long-term illness scheme, having regard to obligations to provide reasonable accommodation for persons with disabilities; and if not, when such an assessment will be initiated. [12153/26]
Amharc ar fhreagraI propose to take Questions Nos. 1138 and 1139 together.
Monitored Dosage Systems, also known as "blister packs", are a privately funded service offered by many pharmacists. They have never been funded by the State. To date there has been no clinical or impact risk assessment conducted in respect of any patient population.
